Our results indicated that OCOP eminently alleviated acute colitis elicited by DSS, which exhibited similar anti-UC effect to the reference drug mesalazine (MSZ) with much smaller dosage and superior to COP via regulation of NF-κB pathway and NLRP3 inflammasome. The gene discussed is NLRP3; the disease is colitis.